Lymphomatoid granulomatosis: Challenges in diagnosis and treatment

Clinical Advances in Hematology and Oncology

Volumn 7, Issue 1, 2009, Pages 68-70

  Gitelson, Elena ^a   Al Saleem, Tahseen ^a   Smith, Mitchell R ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; METHOTREXATE; PREDNISONE; RITUXIMAB; STEROID; VINCRISTINE;

AUTOIMMUNE HEPATITIS; B CELL LYMPHOMA; B LYMPHOCYTE; BRAIN BIOPSY; BRAIN DAMAGE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESEARCH; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; IMMUNOCOMPROMISED PATIENT; LYMPHOMATOID GRANULOMATOSIS; MALIGNANT TRANSFORMATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PATHOGENESIS; REVIEW; RHEUMATOID ARTHRITIS; WEGENER GRANULOMATOSIS;

HUMANS; LYMPHOMATOID GRANULOMATOSIS;

EID: 63449123537     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. L. Martin K, Porcu P, Baiocchi RA, Erter JW, Chaudhury AR. Primary central nervous system lymphomatoid granulomatosis in a patient receiving azathioprine therapy. Clin Adv Hematol Oncol. 2009;7:65-68.
2. Liebow AA, Carrington CR, Friedman PJ. Lymphomatoid granulomatosis. Hum Pathol. 1972;3:457-558.
3. Pittaluga S, Wilson WH, Jaffe ES In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri, SA, Stein H, Thiele J, Vardiman JW, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon: IARC; 2008:247-249.
4. Carbone A, Gloghini A, Dotti G. EBV-associated lymphoproliferative disorders: classification and treatment. Oncologist. 2008;13:577-585.
5. Teruya-Feldstein J, Jaffe ES, Burd PR, et al. The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease. Blood. 1997;90:4099-4105.
6. Lundell RB, Weenig RH, Gibson LE. Lymphomatoid granulomatosis. Cancer Treat Res. 2008;142:265-272.
7. Okuda T, Akai F, Kataoka K, Taneda M. A case of lymphomatoid granulomatosis followed for 14 months on the basis of clinical and histological findings. Brain Tumor Pathol. 2008;25:33-38.
8. Kokmen E, Billman JK, Jr Abell MR. Lymphomatoid granulomatosis clinically confined to the CNS. A case report. Arch Neurol. 1977;34:782-784.
9. Mizuno T, Takanashi Y, Onodera H, et al. A case of lymphomatoid granulomatosis/angiocentric immunoproliferative lesion with long clinical course and diffuse brain involvement. J Neurol Sci. 2003;213:67-76.
10. Katzenstein AL, Carrington CB, Liebow AA. Lymphomatoid granulomatosis: a clinicopathologic study of 152 cases. Cancer. 1979;43:360-373.
11. Patsalides AD, Atac G, Hedge U, et al. Lymphomatoid granulomatosis: abnormalities of the brain at MR imaging. Radiology. 2005;237:265-273.
12. Varoczy L, Gergely L, Szakall S, Illes A. Angiocentric lymphomatoid granulomatosis and severe hypogammaglobulinaemia. Haematologia (Budap). 2002;32:535-541.
13. Shimada K, Matsui T, Kawakami M, et al. Methotrexate-related lymphomatoid granulomatosis: a case report of spontaneous regression of large tumours in multiple organs after cessation of methotrexate therapy in rheumatoid arthritis. Scand J Rheumatol. 2007;36:64-67.
14. Issakhanian M, Chang L, Cornford M, et al. HIV-2 infection with cerebral toxoplasmosis and lymphomatoid granulomatosis. J Neuroimaging. 2001;11:212-216.
15. Sebire NJ, Haselden S, Malone M, Davies EG, Ramsay AD. Isolated EBV lymphoproliferative disease in a child with Wiskott-Aldrich syndrome manifesting as cutaneous lymphomatoid granulomatosis and responsive to anti-CD20 immunotherapy. J Clin Pathol. 2003;56:555-557.
16. Agarwal V, Agarwal A, Pal L, Misra R. Arthritis in lymphomatoid granulomatosis: report of a case and review of literature. Indian J Med Sci. 2004;58:67-71.
17. Jaffre S, Jardin F, Dominique S, et al. Fatal haemoptysis in a case of lymphomatoid granulomatosis treated with rituximab. Eur Respir J. 2006;27:644-646.
18. Zaidi A, Kampalath B, Peltier WL, Vesole DH. Successful treatment of systemic and central nervous system lymphomatoid granulomatosis with rituximab. Leuk Lymphoma. 2004;45:777-780.
19. Jordan K, Grothey A, Grothe W, Kegel T, Wolf HH, Schmoll HJ. Successful treatment of mediastinal lymphomatoid granulomatosis with rituximab monotherapy. Eur J Haematol. 2005;74:263-266.
20. Ishiura H, Morikawa M, Hamada M, et al. Lymphomatoid granulomatosis involving central nervous system successfully treated with rituximab alone. Arch Neurol. 2008;65:662-665.
21. Rao R, Vugman G, Leslie WT, Loew J, Venugopal P. Lymphomatoid granulomatosis treated with rituximab and chemotherapy. Clin Adv Hematol Oncol 2003;1:658-660; discussion 660.
22. Petrella TM, Walker IR, Jones GW, Leber B. Radiotherapy to control CNS lymphomatoid granulomatosis: a case report and review of the literature. Am J Hematol. 1999;62:239-241.
23. Bushunow PW, Casas V, Duggan DB. Lymphomatoid granulomatosis causing central diabetes insipidus: case report and review of the literature. Cancer Invest. 1996;14:112-119.